US 10920223
Serpina1 iRNA compositions and methods of use thereof
granted A61KA61K31/712A61K31/713
Quick answer
US patent 10920223 (Serpina1 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K31/712, A61K31/713, A61P, A61P1/00